Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - darunavirum - filmtabletten - darunavirum 400 mg bis darunavirum ethanolicum, color.: e 110, excipiens pro compresso dunst. - hiv-infektionen - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - darunavirum - filmtabletten - darunavirum 600 mg ut darunavirum ethanolum, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 4000, talcum, e 110 2.75 mg, e 171, pro compresso obducto. - hiv-infektionen - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - darunavirum - filmtabletten - darunavirum 800 mg ut darunavirum ethanolum, hypromellosum, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 4000, talcum, e 171, e 172 (rubrum), pro compresso obducto. - hiv-infektionen - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - darunavirum - orale suspension - darunavirum 100 mg ut darunavirum ethanolum, hydroxypropylcellulosum, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, sucralosum, acidum hydrochloridum concentratum, aromatica (geschmacksüberdeckungsaroma), aromatica (erdbeer), e 219 3.43 mg, aqua purificata ad suspensionem pro 1 ml corresp. natrium 570 µg. - hiv-infektionen - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - daclatasvirum - filmtabletten - tablette: daclatasvirum 30 mg zu daclatasviri dihydrochloridum, color.: e 132, excipiens pro compresso dunst. - chronische hepatitis c - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - daclatasvirum - filmtabletten - daclatasvirum 60 mg zu daclatasviri dihydrochloridum, color.: e 132, excipiens pro compresso dunst. - chronische hepatitis c - synthetika

Europäische Union - Deutsch - EMA (European Medicines Agency)

gilead sciences ireland uc - emtricitabin, tenofovir alafenamide - hiv-infektionen - antivirale mittel zur systemischen anwendung - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv-1).

Europäische Union - Deutsch - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv-infektionen - antivirale mittel zur systemischen anwendung - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 und 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 und 5.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - tenofovirum alafenamidum - filmtabletten - tenofovirum alafenamidum 25 mg zu tenofoviri alafenamidi hemifumaras, lactosum monohydricum 94.96 mg, cellulosum microcristallinum, carmellosum natricum nur zusammengehalten, magnesium stearas, Überzug: poly(alkohol vinylicus), macrogolum, talkum, e 171, e 172 (gelb), für compresso haze endwerte. natrium 1.331 mg. - chronische hepatitis b - synthetika

Europäische Union - Deutsch - EMA (European Medicines Agency)

gilead sciences ireland uc - tenofoviralafenamidfumarat - hepatitis b - antivirale mittel zur systemischen anwendung - vemlidy is indicated for the treatment of chronic hepatitis b (chb) in adults and paediatric patients 6 years of age and older weighing at least 25 kg (see section 5.